Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299–312.

Article  PubMed  Google Scholar 

Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157:1552–62.

Article  CAS  PubMed  Google Scholar 

Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Primers. 2016;2:16065 https://doi.org/10.1038/nrdp.2016.65

Article  PubMed  Google Scholar 

Brunier A. COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide. WHO website (2022). https://www.who.int/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide.

Fang M, Li Y, Liao Z, Wang G, Cao Q, Li Y, et al. Lipopolysaccharide-binding protein expression is increased by stress and inhibits monoamine synthesis to promote depressive symptoms. Immunity. 2023;56:620–34.e611. https://doi.org/10.1016/j.immuni.2023.02.002

Article  CAS  PubMed  Google Scholar 

Eyre HA, Air T, Pradhan A, Johnston J, Lavretsky H, Stuart MJ, et al. A meta-analysis of chemokines in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;68:1–8. https://doi.org/10.1016/j.pnpbp.2016.02.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee CH, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol. 2019;10:1696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pérez-Sánchez G, Becerril-Villanueva E, Arreola R, Martínez-Levy G, Hernández-Gutiérrez ME, Velasco-Velásquez MA, et al. Inflammatory profiles in depressed adolescents treated with fluoxetine: an 8-week follow-up open study. Mediators Inflamm. 2018; 4074051. https://doi.org/10.1155/2018/4074051.

Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation. 2011;8:94 https://doi.org/10.1186/1742-2094-8-94

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wright CE, Strike PC, Brydon L, Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun. 2005;19:345–50.

Article  CAS  PubMed  Google Scholar 

Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013;70:812–20. https://doi.org/10.1001/jamapsychiatry.2013.1111

Article  PubMed  Google Scholar 

Villarino AV, Kanno Y, O’Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol. 2017;18:374–84.

Article  CAS  PubMed  Google Scholar 

Nicolas CS, Amici M, Bortolotto ZA, Doherty A, Csaba Z, Fafouri A, et al. The role of JAK-STAT signaling within the CNS. Jakstat. 2013;2:e22925 https://doi.org/10.4161/jkst.22925

Article  PubMed  PubMed Central  Google Scholar 

Di Benedetto P, Ruscitti P, Berardicurti O, Panzera N, Grazia N, Di Vito Nolfi M, et al. Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis. Arthritis Res Ther. 2021;23:213 https://doi.org/10.1186/s13075-021-02587-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maes M, Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Gałecki P, et al. The immune profile of major dysmood disorder: proof of concept and mechanism using the precision nomothetic psychiatry approach. Cells. 2022; 11; https://doi.org/10.3390/cells11071183.

Tian RH, Bai Y, Li JY, Guo KM. Reducing PRLR expression and JAK2 activity results in an increase in BDNF expression and inhibits the apoptosis of CA3 hippocampal neurons in a chronic mild stress model of depression. Brain Res. 2019;1725:146472.

Article  CAS  PubMed  Google Scholar 

Shariq AS, Brietzke E, Rosenblat JD, Pan Z, Rong C, Ragguett RM, et al. Therapeutic potential of JAK/STAT pathway modulation in mood disorders. Rev Neurosci. 2018;30:1–7. https://doi.org/10.1515/revneuro-2018-0027

Article  CAS  PubMed  Google Scholar 

Fukuyama T, Tschernig T, Qi Y, Volmer DA, Bäumer W. Aggression behaviour induced by oral administration of the Janus-kinase inhibitor tofacitinib, but not oclacitinib, under stressful conditions. Eur J Pharmacol. 2015;764:278–82.

Article  CAS  PubMed  Google Scholar 

Traves PG, Murray B, Campigotto F, Galien R, Meng A, Di Paolo JA. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib. Ann Rheum Dis. 2021;80:865–75. https://doi.org/10.1136/annrheumdis-2020-219012

Article  CAS  PubMed  Google Scholar 

Citera G, Jain R, Irazoque F, Madariaga H, Gruben D, Wang L, et al. Tofacitinib efficacy in patients with rheumatoid arthritis and probable depression/anxiety: post hoc analysis of phase 3 and 3b/4 randomized controlled trials. Rheumatol Ther. 2024;11:35–50. https://doi.org/10.1007/s40744-023-00612-7

Article  PubMed  Google Scholar 

Cao P, Chen C, Liu A, Shan Q, Zhu X, Jia C, et al. Early-life inflammation promotes depressive symptoms in adolescence via microglial engulfment of dendritic spines. Neuron. 2021;109:2573–2589.e2579. https://doi.org/10.1016/j.neuron.2021.06.012

Article  CAS  PubMed  Google Scholar 

Dang R, Wang M, Li X, Wang H, Liu L, Wu Q, et al. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway. J Neuroinflammation. 2022;19:41 https://doi.org/10.1186/s12974-022-02400-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dranovsky A, Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry. 2006;59:1136–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dinoto A, Ferrari S, Mariotto S. Treatment options in refractory autoimmune encephalitis. CNS Drugs. 2022;36:919–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996;711:163–74.

Article  CAS  PubMed  Google Scholar 

Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. 2015;96:e52434 https://doi.org/10.3791/52434

Article  Google Scholar 

De-Fraja C, Conti L, Magrassi L, Govoni S, Cattaneo E. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res. 1998;54:320–30.

Article  CAS  PubMed  Google Scholar 

Jang Y, Lee WJ, Lee HS, Chu K, Lee SK, Lee ST. Tofacitinib treatment for refractory autoimmune encephalitis. Epilepsia. 2021;62:e53–e59. https://doi.org/10.1111/epi.16848

Article  CAS  PubMed  Google Scholar 

De Vries LCS, Duarte JM, De Krijger M, Welting O, Van Hamersveld PHP, Van Leeuwen-Hilbers FWM, et al. A JAK1 selective kinase inhibitor and tofacitinib affect macrophage activation and function. Inflamm Bowel Dis. 2019;25:647–60. https://doi.org/10.1093/ibd/izy364

Article  PubMed  Google Scholar 

Ghersi-Egea JF, Mönkkönen KS, Schmitt C, Honnorat J, Fèvre-Montange M, Strazielle N. Blood-brain interfaces and cerebral drug bioavailability. Rev Neurol (Paris). 2009;165:1029–38. https://doi.org/10.1016/j.neurol.2009.09.011

Article  PubMed  Google Scholar 

Di Liberto G, Pantelyushin S, Kreutzfeldt M, Page N, Musardo S, Coras R, et al. Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping. Cell. 2018; 175: https://doi.org/10.1016/j.cell.2018.07.049.

Chabot S, Williams G, Yong VW. Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b. J Clin Invest. 1997;100:604–12.

Article  CAS  PubMed